MX9203126A - Derivados de sulfonilurea y composiciones farmaceuticas que los contienen. - Google Patents
Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.Info
- Publication number
- MX9203126A MX9203126A MX9203126A MX9203126A MX9203126A MX 9203126 A MX9203126 A MX 9203126A MX 9203126 A MX9203126 A MX 9203126A MX 9203126 A MX9203126 A MX 9203126A MX 9203126 A MX9203126 A MX 9203126A
- Authority
- MX
- Mexico
- Prior art keywords
- sulfonilurea
- derivatives
- contain
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77935485A | 1985-09-23 | 1985-09-23 | |
| US88867586A | 1986-07-24 | 1986-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9203126A true MX9203126A (es) | 1992-07-01 |
Family
ID=27119572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9203126A MX9203126A (es) | 1985-09-23 | 1992-06-22 | Derivados de sulfonilurea y composiciones farmaceuticas que los contienen. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0222475B1 (es) |
| JP (1) | JPH0662548B2 (es) |
| KR (1) | KR880000204B1 (es) |
| CN (1) | CN1013198B (es) |
| AU (1) | AU587064B2 (es) |
| CY (1) | CY1659A (es) |
| DE (1) | DE3667168D1 (es) |
| DK (1) | DK160981C (es) |
| EG (1) | EG18046A (es) |
| ES (1) | ES2001698A6 (es) |
| GR (1) | GR862353B (es) |
| HK (1) | HK88692A (es) |
| HU (1) | HU200597B (es) |
| IE (1) | IE59588B1 (es) |
| IL (1) | IL80032A (es) |
| MX (1) | MX9203126A (es) |
| NZ (1) | NZ217597A (es) |
| PT (1) | PT83389B (es) |
| SG (1) | SG66892G (es) |
| SU (1) | SU1545939A3 (es) |
| UA (1) | UA5953A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845128A (en) * | 1984-06-27 | 1989-07-04 | Eli Lilly And Company | N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides |
| CA1331464C (en) * | 1987-05-12 | 1994-08-16 | Eli Lilly And Company | Anti-tumor method and compounds |
| HU202487B (en) * | 1988-03-04 | 1991-03-28 | Mta Koezponti Kemiai Kutato In | Process for producing n-sulfonylureas |
| US5216026A (en) * | 1990-07-17 | 1993-06-01 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| ZA915371B (en) * | 1990-07-17 | 1993-03-31 | Lilly Co Eli | Antitumor compositions and methods of treatment |
| US5262440A (en) * | 1991-12-10 | 1993-11-16 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| US5258406A (en) * | 1991-12-20 | 1993-11-02 | Eli Lilly And Company | Sulfonimidamides |
| US5234955A (en) * | 1991-12-20 | 1993-08-10 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| US5254582A (en) * | 1992-02-05 | 1993-10-19 | Eli Lilly And Company | Antitumor compositions and methods |
| US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| US5270329A (en) * | 1992-12-10 | 1993-12-14 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| CA2110524A1 (en) * | 1992-12-10 | 1994-06-11 | Gerald Burr Grindey | Antitumor compositions and methods of treatment |
| ZA941500B (en) * | 1993-03-10 | 1995-09-04 | Lilly Co Eli | Antitumor compositions and methods of treatment |
| US6063911A (en) * | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
| DE69725794T9 (de) * | 1996-08-07 | 2004-12-16 | Tomita Pharmaceutical Co. Ltd., Naruto | Granulat zur Abwasserbehandlung |
| DE69708340T2 (de) * | 1996-08-22 | 2002-05-16 | Dong Wha Pharmaceutical Industrial Co. Ltd., Seoul | Arylsulfonylimidazolon-derivate als antitumormittel |
| ES2156550B1 (es) * | 1999-04-19 | 2002-02-01 | Univ Navarra Publica | Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos. |
| JP5134247B2 (ja) * | 2004-09-13 | 2013-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有化合物の血管新生阻害物質との併用 |
| US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| EP2364699A1 (en) | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Joint use of sulfonamide based compound with angiogenesis inhibitor |
| WO2006090927A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の摂食亢進作用 |
| AU2006217690B2 (en) * | 2005-02-28 | 2012-03-15 | Eisai R & D Management Co., Ltd. | Novel use of sulfonamide compound in combination with angiogenesis inhibitor |
| KR20070108270A (ko) * | 2005-02-28 | 2007-11-08 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 술폰아미드 화합물의 신규 병용 |
| WO2007123274A1 (ja) | 2006-04-20 | 2007-11-01 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の新規感受性マーカー |
| JP2012136435A (ja) * | 2009-03-30 | 2012-07-19 | Eisai R & D Management Co Ltd | 腫瘍組織の感受性を検査する方法 |
| CN102993106B (zh) * | 2012-12-24 | 2015-06-17 | 武汉武药制药有限公司 | 格列吡嗪的合成新路线 |
| GB201618240D0 (en) * | 2016-10-27 | 2016-12-14 | Trade Vehicle Locks Ltd | Apparatus for locking a door of a vehicle |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1144259B (de) * | 1956-05-29 | 1963-02-28 | Hoechst Ag | Verfahren zur Herstellung von Sulfonylharnstoffen |
| DE1159937B (de) * | 1960-06-29 | 1963-12-27 | Heyden Chem Fab | Verfahren zur Herstellung von Hydrindensulfonylharnstoffen |
| US3097242A (en) * | 1960-06-29 | 1963-07-09 | Olin Mathieson | Hydrindene sulfonylureas |
| DE1240866B (de) * | 1961-06-29 | 1967-05-24 | Heyden Chem Fab | Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen |
| US4634465A (en) * | 1982-07-16 | 1987-01-06 | Ciba-Geigy Corporation | Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas |
| IT1161220B (it) * | 1983-04-21 | 1987-03-18 | Montedison Spa | Diidro-benzofurano derivati ad attivita' erbicida |
| US4845128A (en) * | 1984-06-27 | 1989-07-04 | Eli Lilly And Company | N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides |
-
1986
- 1986-09-15 IL IL80032A patent/IL80032A/xx not_active IP Right Cessation
- 1986-09-15 GR GR862353A patent/GR862353B/el unknown
- 1986-09-16 NZ NZ217597A patent/NZ217597A/xx unknown
- 1986-09-16 PT PT83389A patent/PT83389B/pt active IP Right Revival
- 1986-09-17 EP EP86307158A patent/EP0222475B1/en not_active Expired
- 1986-09-17 DE DE8686307158T patent/DE3667168D1/de not_active Expired - Lifetime
- 1986-09-18 DK DK446986A patent/DK160981C/da not_active IP Right Cessation
- 1986-09-19 IE IE250386A patent/IE59588B1/en not_active IP Right Cessation
- 1986-09-19 AU AU62942/86A patent/AU587064B2/en not_active Ceased
- 1986-09-21 EG EG592/86A patent/EG18046A/xx active
- 1986-09-22 SU SU4028196A patent/SU1545939A3/ru active
- 1986-09-22 UA UA4028196A patent/UA5953A1/uk unknown
- 1986-09-22 HU HU864014A patent/HU200597B/hu not_active IP Right Cessation
- 1986-09-22 CN CN86106428A patent/CN1013198B/zh not_active Expired
- 1986-09-22 KR KR1019860007904A patent/KR880000204B1/ko not_active IP Right Cessation
- 1986-09-22 ES ES8602077A patent/ES2001698A6/es not_active Expired
- 1986-09-22 JP JP61224064A patent/JPH0662548B2/ja not_active Expired - Fee Related
-
1992
- 1992-06-22 MX MX9203126A patent/MX9203126A/es unknown
- 1992-07-01 SG SG668/92A patent/SG66892G/en unknown
- 1992-11-12 HK HK886/92A patent/HK88692A/xx not_active IP Right Cessation
-
1993
- 1993-05-14 CY CY1659A patent/CY1659A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU587064B2 (en) | 1989-08-03 |
| NZ217597A (en) | 1989-06-28 |
| JPH0662548B2 (ja) | 1994-08-17 |
| PT83389B (pt) | 1989-05-12 |
| CN86106428A (zh) | 1987-03-18 |
| CN1013198B (zh) | 1991-07-17 |
| HU200597B (en) | 1990-07-28 |
| JPS6296459A (ja) | 1987-05-02 |
| IL80032A (en) | 1992-07-15 |
| SU1545939A3 (ru) | 1990-02-23 |
| DK446986D0 (da) | 1986-09-18 |
| SG66892G (en) | 1992-09-04 |
| AU6294286A (en) | 1987-03-26 |
| IE59588B1 (en) | 1994-03-09 |
| HUT46657A (en) | 1988-11-28 |
| CY1659A (en) | 1993-05-14 |
| UA5953A1 (uk) | 1994-12-29 |
| EP0222475B1 (en) | 1989-11-29 |
| HK88692A (en) | 1992-11-20 |
| PT83389A (en) | 1986-10-01 |
| KR880000204B1 (ko) | 1988-03-12 |
| IE862503L (en) | 1987-03-23 |
| DK446986A (da) | 1987-03-24 |
| ES2001698A6 (es) | 1988-06-01 |
| DE3667168D1 (de) | 1990-01-04 |
| DK160981C (da) | 1991-10-28 |
| DK160981B (da) | 1991-05-13 |
| EG18046A (en) | 1991-08-30 |
| GR862353B (en) | 1987-01-19 |
| KR870003086A (ko) | 1987-04-15 |
| EP0222475A1 (en) | 1987-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9203126A (es) | Derivados de sulfonilurea y composiciones farmaceuticas que los contienen. | |
| MX9203040A (es) | Derivados de quinona y composicion farmaceutica que los contiene. | |
| MX9202934A (es) | Derivados de carbostirilo y composicion farmaceutica que los contiene. | |
| MX9203027A (es) | Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen. | |
| MX9203226A (es) | Derivados de fenetanolamina y composicion farmaceutica que los contiene. | |
| MX9202910A (es) | Nuevos derivados de dihidropiridina y composicion farmaceutica que los contiene. | |
| MX9202851A (es) | Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene. | |
| MX9203177A (es) | Derivados de 1-fluorofenilbutil-4-(2-pirimidinil)piperazina y composiciones farmaceuticas que los contienen. | |
| MX9203114A (es) | Nuevos derivados morfolino de daunorubicina y doxorubicina y composiciones farmaceuticas que los contienen. | |
| MX9203380A (es) | Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen. | |
| MX9203108A (es) | Compuestos de di-t-butilfenol y composiciones que los contienen. | |
| MX9204563A (es) | Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende. | |
| MX9202935A (es) | Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene. | |
| MX9203628A (es) | Compuestos florados de benciltriazol y composiciones farmaceuticas que los contienen. | |
| MX9202763A (es) | Nuevos derivados de 2-(1-piperazinil)-4-fenil-cicloalcanopiridina y composicion farmaceutica que los contiene. | |
| MX9203639A (es) | 3-fenoxi-1-azetidincarboxamidas y composiciones farmaceuticas que las contienen. | |
| ES2012045B3 (es) | Derivados amidicos y medicamentos de uso externo que los contienen. | |
| MX9203613A (es) | Derivados de adenosina y composiciones farmaceuticas que los contienen. | |
| MX174530B (es) | Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen | |
| MX9203021A (es) | Derivados de carbostirilo y composicion farmaceutica que los contiene. | |
| MX9203383A (es) | Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen. | |
| ES2023151B3 (es) | Derivados de p-hidroxicinamamida e inhibidor de melanina que los contiene. | |
| MX9203632A (es) | Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen. | |
| MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. | |
| MX9203235A (es) | Derivados de tetrahidronaftaleno e indano y composiciones farmaceuticas que los contienen. |